PI
Putnam Investments Portfolio holdings
AUM
$75.7B
1-Year Return
34.47%
This Quarter Return
+9.46%
1 Year Return
+34.47%
3 Year Return
+62.08%
5 Year Return
+203.67%
10 Year Return
+403.53%
AUM
$64.3B
AUM Growth
+$4.28B
(+7.1%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-1.82%
Top 10 Holdings %
Top 10 Hldgs %
24.55%
Holding
882
New
119
Increased
256
Reduced
326
Closed
109
Top Buys
| 1 |
Elevance Health
ELV
|
$430M |
| 2 |
O'Reilly Automotive
ORLY
|
$350M |
| 3 |
Thermo Fisher Scientific
TMO
|
$338M |
| 4 |
Oracle
ORCL
|
$273M |
| 5 |
Cadence Design Systems
CDNS
|
$198M |
Top Sells
| 1 |
Sherwin-Williams
SHW
|
$473M |
| 2 |
Cigna
CI
|
$412M |
| 3 |
Home Depot
HD
|
$364M |
| 4 |
Amgen
AMGN
|
$314M |
| 5 |
Cisco
CSCO
|
$276M |
Sector Composition
| 1 | Technology | 23.55% |
| 2 | Financials | 14.35% |
| 3 | Healthcare | 14.25% |
| 4 | Consumer Discretionary | 12.44% |
| 5 | Industrials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Etsy
ETSY
$5.36B
| $68.2M | 0.11% |
331,285
-20,236
| -6% | -$4.17M |
|
152
Levi Strauss
LEVI
$8.79B
| $65.5M | 0.1% |
2,362,264
-200,003
| -8% | -$5.54M |
|
153
Lam Research
LRCX
$130B
| $64.7M | 0.1% |
993,710
-6,000
| -0.6% | -$390K |
|
154
Altria Group
MO
$112B
| $64.4M | 0.1% |
1,350,135
-85,567
| -6% | -$4.08M |
|
155
Lockheed Martin
LMT
$108B
| $63.8M | 0.1% |
168,652
-8,481
| -5% | -$3.21M |
|
156
Consumers Staples Select Sector SPDR Fund
XLP
$15.8B
| $63.7M | 0.1% |
910,631
+722,179
| +383% | +$50.5M |
|
157
GE Aerospace
GE
$296B
| $63.3M | 0.1% |
942,870
+1,255
| +0.1% | +$84.2K |
|
|
158
Cigna
CI
$81.5B
| $63M | 0.1% |
265,886
-1,737,842
| -87% | -$412M |
|
159
Best Buy
BBY
$16.1B
| $63M | 0.1% |
547,499
-11,789
| -2% | -$1.36M |
|
160
Ironwood Pharmaceuticals
IRWD
$188M
| $61M | 0.09% |
4,737,415
+1,388,883
| +41% | +$17.9M |
|
161
ON Semiconductor
ON
$20.1B
| $60.3M | 0.09% |
1,574,845
-862,567
| -35% | -$33M |
|
162
Morgan Stanley
MS
$236B
| $59.5M | 0.09% |
648,446
-273,918
| -30% | -$25.1M |
|
163
Ascendis Pharma
ASND
$12.5B
| $55.4M | 0.09% |
421,473
+320,657
| +318% | +$42.2M |
|
164
Biogen
BIIB
$20.6B
| $52.9M | 0.08% |
152,742
-74,536
| -33% | -$25.8M |
|
165
Roku
ROKU
$14B
| $52.2M | 0.08% |
113,696
+83,441
| +276% | +$38.3M |
|
166
Ryanair
RYAAY
$32.1B
| $51.4M | 0.08% |
1,186,523
+75,460
| +7% | +$3.27M |
|
167
Bio-Rad Laboratories Class A
BIO
$8B
| $50.4M | 0.08% |
78,179
+1,060
| +1% | +$683K |
|
168
Clarivate
CLVT
$2.96B
| $50.2M | 0.08% |
+1,822,449
| New | +$50.2M |
|
169
CBRE Group
CBRE
$48.9B
| $48.4M | 0.08% |
564,082
+17,491
| +3% | +$1.5M |
|
170
Coca-Cola
KO
$292B
| $48.1M | 0.07% |
888,005
-454,370
| -34% | -$24.6M |
|
171
MetLife
MET
$52.9B
| $47.7M | 0.07% |
796,611
-36,042
| -4% | -$2.16M |
|
172
Ford
F
$46.7B
| $47.4M | 0.07% |
3,190,713
-2,771,394
| -46% | -$41.2M |
|
173
Hasbro
HAS
$11.2B
| $46.8M | 0.07% |
494,821
+1,111
| +0.2% | +$105K |
|
174
Align Technology
ALGN
$10.1B
| $46.5M | 0.07% |
+76,183
| New | +$46.5M |
|
175
Shift4
FOUR
$6.01B
| $45.4M | 0.07% |
484,573
+231,305
| +91% | +$21.7M |
|